The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
Open accessAbstract
Infant high-grade gliomas appear clinically distinct from their counterparts in older children, indicating that histopathologic grading may not accurately reflect the biology of these tumors. We have collected 241 cases under 4 years of age, and carried out histologic review, methylation profiling, and custom panel, genome, or exome sequencing. After excluding tumors representing other established entities or subgroups, we identified 130 cases to be part of an “intrinsic” spectrum of disease specific to the infant population. These included those with targetable MAPK alterations, and a large proportion of remaining cases harboring gene fusions targeting ALK (n = 31), NTRK1/2/3 (n = 21), ROS1 (n = 9), and MET (n = 4) as their driving alterations, with evidence of efficacy of targeted agents in the clinic. These data strongly support the concept that infant gliomas require a change in diagnostic practice and management. Significance: Infant high-grade gliomas in the cerebral hemispheres comprise novel subgroups, with a prevalence of ALK, NTRK1/2/3, ROS1, or MET gene fusions. Kinase fusion–positive tumors have better outcome and respond to targeted therapy clinically. Other subgroups have poor outcome, with fusion-negative cases possibly representing an epigenetically driven pluripotent stem cell phenotype. See related video: https://vimeo.com/438254885 See related commentary by Szulzewsky and Cimino, p. 904. This article is highlighted in the In This Issue feature, p. 890
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
Self-citationImproving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
DNA methylation-based classification of central nervous system tumours
Capper, D., Jones, D. T. W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chavez, L., Reuss, D. E., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,033
Self-citationDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · cited 2×
“1 ( HIST1H3B/C ) including two recurrent amino acid substitutions (K27M and G34R/V; refs.”
BackgroundSelf-citationSturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
Self-citationSt. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Guidelines for the welfare and use of animals in cancer research
An ad hoc committee of the National Cancer Research Institute, Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J., Double, J. A., Everitt, J., Farningham, D. A. H., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605642 · Cited by 1,442
Mackay, A., Burford, A., Carvalho, D., Izquierdo, E., Fazal-Salom, J., Taylor, K. R., Bjerke, L., Clarke, M., Vinci, M., Nandhabalan, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.017 · Cited by 1,212
Self-citationthe St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Sturm, D., Orr, B. A., Toprak, U. H., Hovestadt, V., Jones, D. T. W., Capper, D., Sill, M., Buchhalter, I., Northcott, P. A., Leis, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.015 · Cited by 975
Self-citationThe MAP1 family of microtubule-associated proteins.
Dehmelt (2004) · Genome biology · doi:10.1186/gb-2004-6-1-204 · Cited by 972
Bouffet, E., Larouche, V., Campbell, B. B., Merico, D., de Borja, R., Aronson, M., Durno, C., Krueger, J., Cabric, V., Ramaswamy, V., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.6552 · Cited by 857
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2013) · Nature Genetics · doi:10.1038/ng.2611 · Cited by 835
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
the International Cancer Genome Consortium PedBrain Tumor Project, Jones, D. T. W., Hutter, B., Jäger, N., Korshunov, A., Kool, M., Warnatz, H.-J., Zichner, T., Lambert, S. R., Ryzhova, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2682 · Cited by 825
Self-citationTransforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Singh, D., Chan, J. M., Zoppoli, P., Niola, F., Sullivan, R., Castano, A., Liu, E. M., Reichel, J., Porrati, P., Pellegatta, S., et al. (2012) · Science · doi:10.1126/science.1220834 · Cited by 789
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Amatu, A., Sartore-Bianchi, A., & Siena, S. (2016) · ESMO Open · doi:10.1136/esmoopen-2015-000023 · Cited by 601
Molecular characterization of cancers with NTRK gene fusions
Gatalica, Z., Xiu, J., Swensen, J., & Vranic, S. (2019) · Modern Pathology · doi:10.1038/s41379-018-0118-3 · Cited by 486
Akt/PKB Regulates Actin Organization and Cell Motility via Girdin/APE
Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., Murakumo, Y., Usukura, J., Kaibuchi, K., & Takahashi, M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.08.001 · Cited by 418
Qaddoumi, I., Orisme, W., Wen, J., Santiago, T., Gupta, K., Dalton, J. D., Tang, B., Haupfear, K., Punchihewa, C., Easton, J., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1539-z · Cited by 409
Self-citationfor the Biallelic Mismatch Repair Deficiency Consortium, Shlien, A., Campbell, B. B., de Borja, R., Alexandrov, L. B., Merico, D., Wedge, D., Van Loo, P., Tarpey, P. S., Coupland, P., et al. (2015) · Nature Genetics · doi:10.1038/ng.3202 · Cited by 374
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
Guerreiro Stucklin, A. S., Ryall, S., Fukuoka, K., Zapotocky, M., Lassaletta, A., Li, C., Bridge, T., Kim, B., Arnoldo, A., Kowalski, P. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12187-5 · Cited by 367
Okamura, R., Boichard, A., Kato, S., Sicklick, J. K., Bazhenova, L., & Kurzrock, R. (2018) · JCO Precision Oncology · doi:10.1200/po.18.00183 · Cited by 328
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
Pietrantonio, F., Di Nicolantonio, F., Schrock, A. B., Lee, J., Tejpar, S., Sartore-Bianchi, A., Hechtman, J. F., Christiansen, J., Novara, L., Tebbutt, N., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx089 · Cited by 317
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Jones, C., & Baker, S. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3811 · Cited by 298
Self-citationJohnson, A., Severson, E., Gay, L., Vergilio, J.-A., Elvin, J., Suh, J., Daniel, S., Covert, M., Frampton, G. M., Hsu, S., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0242 · Cited by 269
Paediatric and adult malignant glioma: close relatives or distant cousins?
Jones, C., Perryman, L., & Hargrave, D. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.87 · Cited by 243
Self-citationRecurrent MET fusion genes represent a drug target in pediatric glioblastoma
International Cancer Genome Consortium PedBrain Tumor Project (2016) · Nature Medicine · doi:10.1038/nm.4204 · Cited by 233
Mackay, A., Burford, A., Molinari, V., Jones, D. T. W., Izquierdo, E., Brouwer-Visser, J., Giangaspero, F., Haberler, C., Pietsch, T., Jacques, T. S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.004 · Cited by 221
Self-citationCharest, A., Lane, K., McMahon, K., Park, J., Preisinger, E., Conroy, H., & Housman, D. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10207 · Cited by 211
Ren, X., & Kuan, P. F. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty892 · Cited by 203
Duffner, P. K., Horowitz, M. E., Krischer, J. P., Burger, P. C., Cohen, M. E., Sanford, R. A., Friedman, H. S., & Kun, L. E. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.2.152 · Cited by 201
The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas
Johannessen, A. L., & Torp, S. H. (2006) · Pathology & Oncology Research · doi:10.1007/bf02893360 · Cited by 187
Infarinato, N. R., Park, J. H., Krytska, K., Ryles, H. T., Sano, R., Szigety, K. M., Li, Y., Zou, H. Y., Lee, N. V., Smeal, T., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1056 · Cited by 183
Kalashnikova, E., Lorca, R. A., Kaur, I., Barisone, G. A., Li, B., Ishimaru, T., Trimmer, J. S., Mohapatra, D. P., & Díaz, E. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.021 · Cited by 173
Gripp, K. W., Aldinger, K. A., Bennett, J. T., Baker, L., Tusi, J., Powell‐Hamilton, N., Stabley, D. L., Sol‐Church, K., Timms, A. E., & Dobyns, W. B. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37781 · Cited by 171
Koelsche, C., Mynarek, M., Schrimpf, D., Bertero, L., Serrano, J., Sahm, F., Reuß, D., Hou, Y., Baumhoer, D., Vokuhl, C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1871-6 · Cited by 143
Self-citationExpanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors
Davis, J. L., Lockwood, C. M., Stohr, B. A., Boecking, C. A., Al‐Ibraheemi, A., DuBois, S. G., Vargas, S. O., Black, J. O., Cox, M. C., Luquette, M. H., et al. (2018) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001203 · Cited by 140
Metzler, M., Li, B., Gan, L., Georgiou, J., Gutekunst, C., Wang, Y., Torre, E. R., Devon, R. S., Oh-McGinnis, R., Legendre‐Guillemin, V., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg334 · Cited by 135
Ziegler, D. S., Wong, M., Mayoh, C., Kumar, A., Tsoli, M., Mould, E. V. A., Tyrrell, V. J., Khuong-Quang, D.-A., Pinese, M., Gayevskiy, V., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0251-2 · Cited by 116
Self-citationChmielecki, J., Bailey, M., He, J., Elvin, J. A., Vergilio, J., Ramkissoon, S. H., Suh, J. H., Frampton, G. M., Sun, J., Morley, S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1106 · Cited by 102
Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer
Farago, A. F., & Azzoli, C. G. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.08.02 · Cited by 101
NAKAI, T., Nagai, T., Tanaka, M., Itoh, N., Asai, N., Enomoto, A., Asai, M., Yamada, S., Saifullah, A. B., Sokabe, M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2228-14.2014 · Cited by 97
Deficiency of the Cytoskeletal Protein SPECC1L Leads to Oblique Facial Clefting
Saadi, I., Alkuraya, F. S., Gisselbrecht, S. S., Goessling, W., Cavallesco, R., Turbé-Doan, A., Petrin, A. L., Harris, J. M., Siddiqui, U., Grix, A. W., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.023 · Cited by 90
High-grade glioma in very young children: a rare and particular patient population
El‐Ayadi, M., Ansari, M., Sturm, D., Gielen, G. H., Warmuth‐Metz, M., Kramm, C. M., & von Bueren, A. O. (2017) · Oncotarget · doi:10.18632/oncotarget.18478 · Cited by 63
Self-citationThe Mad Protein Family Links Transcriptional Repression to Cell Differentiation
McArthur, G. A., Laherty, C. D., Quéva, C., Hurlin, P. J., Loo, L. W. M., JAMES, L., Grandori, C., Gallant, P., Shiio, Y., Hokanson, W., et al. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.423 · Cited by 61
Current Treatment Approaches for Infants with Malignant Central Nervous System Tumors
Lafay‐Cousin, L., & Strother, D. R. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0193 · Cited by 59
Davare, M. A., Henderson, J. J., Agarwal, A., Wagner, J. P., Iyer, S. R., Shah, N., Woltjer, R. L., Somwar, R., Gilheeney, S. W., DeCarvalo, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1052 · Cited by 57
Self-citationWang, A., Jones, D., Abecassis, I. J., Cole, B., Leary, S. E. S., Lockwood, C. M., Chávez, L., Capper, D., Korshunov, A., Fallah, A., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0507 · Cited by 56
Self-citationClinical and molecular characteristics of congenital glioblastoma
Macy, M. E., Birks, D. K., Barton, V. N., Chan, M. H., Donson, A. M., Kleinschmidt-DeMasters, B. K., Bemis, L., Handler, M. H., & Foreman, N. K. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos125 · Cited by 55
Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Olsen, T. K., Panagopoulos, I., Meling, T. R., Micci, F., Gorunova, L., Thorsen, J., Due‐Tønnessen, B. J., Scheie, D., Lund‐Iversen, M., Krossnes, B. K., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov039 · Cited by 53
Self-citationWilson, N. R., Olm-Shipman, A. J., Acevedo, D. S., Palaniyandi, K., Hall, E. G., Kosa, E., Stumpff, K. M., Smith, G. J., Pitstick, L. D., Liao, E. C.-W., et al. (2016) · Scientific Reports · doi:10.1038/srep17735 · Cited by 50
Genetic Analysis of Diffuse High‐Grade Astrocytomas in Infancy Defines a Novel Molecular Entity
Gielen, G. H., Gessi, M., Buttarelli, F. R., Baldi, C., Hammes, J., Muehlen, A. Z., Doerner, E., Denkhaus, D., Warmuth‐Metz, M., Giangaspero, F., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12210 · Cited by 41
Self-citationNovel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor
Kiehna, E. N., Arnush, M., Tamrazi, B., Cotter, J. A., Hawes, D., Robison, N. J., Fong, C. Y., Estrine, D. B., Han, J., & Biegel, J. A. (2017) · Journal of Neurosurgery Pediatrics · doi:10.3171/2017.2.peds16679 · Cited by 21
Cited by
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Self-citationWeller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
Nicholson, J. G., & Fine, H. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1474 · Cited by 460
Horbinski, C., Berger, T., Packer, R. J., & Wen, P. Y. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00679-w · Cited by 312
Self-citationGupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00809-0 · Cited by 7
Metadata
- Authors
- Clarke, M., Mackay, A., Ismer, B., Pickles, J. C., Tatevossian, R. G., Newman, S., Bale, T. A., Stoler, I., Izquierdo, E., Temelso, S., Carvalho, D. M., Molinari, V., Burford, A., Howell, L., Virasami, A., Fairchild, A. R., Avery, A., Chalker, J., Kristiansen, M., Haupfear, K., Dalton, J. D., Orisme, W., Wen, J., Hubank, M., Kurian, K. M., Rowe, C., Maybury, M., Crosier, S., Knipstein, J., Schüller, U., Kordes, U., Kram, D. E., Snuderl, M., Bridges, L., Martin, A. J., Doey, L. J., Al-Sarraj, S., Chandler, C., Zebian, B., Cairns, C., Natrajan, R., Boult, J. K. R., Robinson, S. P., Sill, M., Dunkel, I. J., Gilheeney, S. W., Rosenblum, M. K., Hughes, D., Proszek, P. Z., Macdonald, T. J., Preusser, M., Haberler, C., Slavc, I., Packer, R., Ng, H.-K., Caspi, S., Popović, M., Faganel Kotnik, B., Wood, M. D., Baird, L., Davare, M. A., Solomon, D. A., Olsen, T. K., Brandal, P., Farrell, M., Cryan, J. B., Capra, M., Karremann, M., Schittenhelm, J., Schuhmann, M. U., Ebinger, M., Dinjens, W. N. M., Kerl, K., Hettmer, S., Pietsch, T., Andreiuolo, F., Driever, P. H., Korshunov, A., Hiddingh, L., Worst, B. C., Sturm, D., Zuckermann, M., Witt, O., Bloom, T., Mitchell, C., Miele, E., Colafati, G. S., Diomedi-Camassei, F., Bailey, S., Moore, A. S., Hassall, T. E. G., Lowis, S. P., Tsoli, M., Cowley, M. J., Ziegler, D. S., Karajannis, M. A., Aquilina, K., Hargrave, D. R., Carceller, F., Marshall, L. V., von Deimling, A., Kramm, C. M., Pfister, S. M., Sahm, F., Baker, S. J., Mastronuzzi, A., Carai, A., Vinci, M., Capper, D., Popov, S., Ellison, D. W., Jacques, T. S., Jones, D. T. W., & Jones, C.
- Venue
- Cancer Discovery
- Published
- 2020-07-01
- Volume
- 10
- Issue
- 7
- Pages
- 942-963
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W3014806119
- Cited by
- 271
- References
- 55
- FWCI
- 17.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.